Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-18

Clinical Trial Update: Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin. [Phase 1]

View source ↗

Summary

An open-label Phase 1 trial assessed the drug interaction between eslicarbazepine acetate and phenytoin in epilepsy, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenytoin (Phenytoin)
  • Zebinix (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-18